Marksans Pharma Standalone March 2021 Net Sales at Rs 137.58 crore, up 21.07% Y-o-Y
Net Sales at Rs 137.58 crore in March 2021 up 21.07% from Rs. 113.64 crore in March 2020.
Quarterly Net Profit at Rs. 23.69 crore in March 2021 up 219.63% from Rs. 7.41 crore in March 2020.
EBITDA stands at Rs. 38.68 crore in March 2021 up 111.37% from Rs. 18.30 crore in March 2020.
Marksans Pharma EPS has increased to Rs. 0.58 in March 2021 from Rs. 0.18 in March 2020.
Marksans Pharma shares closed at 73.95 on May 28, 2021 (BSE)